Azora Therapeutics, Inc. (DE) (AZR) Research & Development (2017 - 2026)
Azora Therapeutics, Inc. (DE)'s Research & Development was $1.78 million in Q3 2026, up 240.7% from $521,000 a year earlier and up 303.4% from the prior quarter.
Powered by 
Analysis
Azora Therapeutics, Inc. (DE) (AZR) Research & Development (2017 - 2026) Analysis & Trends
On a trailing twelve-month basis, Azora Therapeutics, Inc. (DE)'s Research & Development was $3.27 million through Sep 30, 2026, up 19.6% year-over-year; for FY2025, it came in at $2.62 million, down 18.9% from FY2024.
- Research & Development shows a five-year compound annual growth rate of -14.9% (FY2020 to FY2025).
- In earlier years, Research & Development was $3.23 million in FY2024 (+154.9%), $1.27 million in FY2023 (-35.0%), $1.95 million in FY2022 (-76.8%) and $8.4 million in FY2021 (+43.4%).
- The Q3 2026 figure marks the highest quarterly Research & Development since Q4 2021.
- Compared with a year earlier, Research & Development was higher in three of the last eight quarters, with growth averaging 38.4%.
- The best year-over-year quarter for Research & Development over five years was Q3 2024 (growth of 398.1%); the worst was Q4 2022 (a decline of 77.2%).
- Per Business Quant data, AZR's Research & Development in the three quarters before Q3 2026 was $440,000 (Q2 2026), $432,530 (Q1 2026) and $619,671 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 3.89 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Azora Therapeutics, Inc. (DE) | 58.43 Mn | -2.79 Mn | - | 1.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.78 Mn |
| Jun 30, 2026 | 440,000.00 |
| Mar 31, 2026 | 432,530.00 |
| Dec 31, 2025 | 619,396.00 |
| Sep 30, 2025 | 521,069.00 |
| Jun 30, 2025 | 732,000.00 |
| Mar 31, 2025 | 746,891.00 |
| Dec 31, 2024 | 730,793.00 |
| Sep 30, 2024 | 1.03 Mn |
| Jun 30, 2024 | 1.01 Mn |
| Mar 31, 2024 | 454,278.00 |
| Dec 31, 2023 | 264,437.00 |
| Sep 30, 2023 | 207,128.00 |
| Jun 30, 2023 | 429,896.00 |
| Mar 31, 2023 | 365,616.00 |
| Dec 31, 2022 | 531,841.00 |
| Sep 30, 2022 | 696,073.00 |
| Jun 30, 2022 | 679,966.00 |
| Mar 31, 2022 | 596,341.00 |
| Dec 31, 2021 | 2.33 Mn |
API Access
Azora Therapeutics, Inc. (DE) Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=AZR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "AZR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=AZR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();